shehla shaikh

Dr. shehla shaikh


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
MHMohamed Hassanein
Mohamed Hassanein
ZHZanariah Hussein
Zanariah Hussein
ISInass Shaltout
Inass Shaltout
WSWan Juani Wan Seman
Wan Juani Wan Seman
CTChin Voon Tong
Chin Voon Tong
MAMuhammad Yakoob Ahmedani
Muhammad Yakoob Ahmedani

21 May 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
SSSalomi Shaikh
Salomi Shaikh
LNLakshmi Nagendra
Lakshmi Nagendra
SSshehla shaikh
shehla shaikh
Joseph M. PappachanJoseph M. Pappachan
Joseph M. Pappachan
The diagnosis of adrenal insufficiency (AI) requires a high index of suspicion, detailed clinical assessment including detailed drug history, and appropriate laboratory evaluation. The clinical characteristics of adrenal insufficiency vary according to the cause, and the presentation may be myriad, e.g. insidious onset to a catastrophic adrenal crisis presenting with circulatory shock and coma. Secondary adrenal insufficiency (SAI) often presents with only glucocorticoid deficiency because aldosterone production, which is controlled by the renin angiotensin system, is usually intact, and rarely presents with an adrenal crisis. Measurements of the basal serum cortisol at 8 am (<140 nmol/L or 5 mcg/dL) coupled with adrenocorticotrophin (ACTH) remain the initial tests of choice. The cosyntropin stimulation (short synacthen) test is used for the confirmation of the diagnosis. Newer highly specific cortisol assays have reduced the cut-off points for cortisol in the diagnosis of AI. The salivary cortisol test is increasingly being used in conditions associated with abnormal cortisol binding globulin (CBG) levels such as pregnancy. Children and infants require lower doses of cosyntropin for testing. 21-hydoxylase antibodies are routinely evaluated to rule out autoimmunity, the absence of which would require secondary causes of adrenal insufficiency to be ruled out. Testing the hypothalamic–pituitary–adrenal (HPA) axis, imaging, and ruling out systemic causes are necessary for the diagnosis of AI. Cancer treatment with immune checkpoint inhibitors (ICI) is an emerging cause of both primary AI and SAI and requires close follow up. Several antibodies are being implicated, but more clarity is required. We update the diagnostic evaluation of AI in this evidence-based review.

2 June 2023 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MHMohamed Hassanein
Mohamed Hassanein
SYSanobia Yousuf
Sanobia Yousuf
MAMuhammad Yakoob Ahmedani
Muhammad Yakoob Ahmedani
AAAlaa Albashier
Alaa Albashier
ISInass Shaltout
Inass Shaltout
MAMajid Alabbood
Majid Alabbood

18 November 2025 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ABAparna Govil Bhasker
Aparna Govil Bhasker
SGShamika Girkar
Shamika Girkar
VJVishakha Jain
Vishakha Jain
TLTejal Lathia
Tejal Lathia
CSChitra Selvan
Chitra Selvan
SSshehla shaikh
shehla shaikh